Portfolio company
DiagonalBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular diagnostic systems for rapid, point-of-care pathogen detection in human healthcare, veterinary, and agricultural markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Magnomics
This company develops portable molecular diagnostic devices using microfluidics and magnetoresistive technology to detect pathogens for human health, veterinary and food industry customers.
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.
Detechgene
This company develops portable molecular testing platforms for clinics, hospitals, and researchers to detect infectious pathogens at the point of care.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
Rapid Myco
This company develops diagnostic tests for the rapid detection of mycobacterial infections in commercial livestock and humans.
Scope Biosciences
This company develops CRISPR-based molecular diagnostic kits for on-site pathogen detection for agricultural growers and healthcare providers.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
